BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22515642)

  • 1. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.
    Guo X; Xiong L; Sun T; Peng R; Zou L; Zhu H; Zhang J; Li H; Zhao J
    Diagn Pathol; 2012 Apr; 7():44. PubMed ID: 22515642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
    Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
    Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma.
    Guo X; Yang M; Gu H; Zhao J; Zou L
    Cancer Epidemiol; 2013 Oct; 37(5):732-6. PubMed ID: 23731550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Guo X; Xiong L; Yu L; Li R; Wang Z; Ren B; Dong J; Li B; Wang D
    Diagn Pathol; 2014 Sep; 9():175. PubMed ID: 25230759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients.
    Zhao ZK; Yu HF; Wang DR; Dong P; Chen L; Wu WG; Ding WJ; Liu YB
    World J Gastroenterol; 2012 Dec; 18(45):6651-6. PubMed ID: 23236241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
    Li B; Shao Q; Ji D; Li F; Guo X; Chen G
    Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
    Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
    Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
    Yu L; Zhang J; Guo X; Li Z; Zhang P
    Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma.
    Kong J; Zhou X; Liu S; Jin T; Piao Y; Liu C; Lin Z
    Int J Clin Exp Pathol; 2014; 7(6):3018-27. PubMed ID: 25031720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
    Li BK; Huang PZ; Qiu JL; Liao YD; Hong J; Yuan YF
    Diagn Pathol; 2014 Dec; 9():226. PubMed ID: 25466449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma.
    Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
    Clin Transl Oncol; 2014 Jan; 16(1):57-63. PubMed ID: 23632812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of relaxin-2 expression in hepatocellular carcinoma: relation with clinicopathological parameters.
    Pan HZ; Dong AB; Wang L; Tan SS; Yang Q; Tong XY; Liang J; Wang JR
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1095-101. PubMed ID: 23661524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma.
    Su ZX; Zhao J; Rong ZH; Geng WM; Wu YG; Qin CK
    Diagn Pathol; 2014 Mar; 9():47. PubMed ID: 24593846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
    Chen XQ; He JR; Wang HY
    Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
    Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
    Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
    Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY
    Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.